The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Incubator/Accelerator | Alive

About BacMuno

BacMuno is a pharmaceutical biotechnology company developing bacteria-based cancer immuno-therapies for humans and animals through the use of unique Salmonella based technology.

BacMuno Headquarter Location

Hong Kong

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BacMuno

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BacMuno is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

  • What is BacMuno's latest funding round?

    BacMuno's latest funding round is Incubator/Accelerator.

  • Who are the investors of BacMuno?

    Investors of BacMuno include Hong Kong X.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.